BLLN three-lens brief
Evidence-based stock research on BLLN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 29.6pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 29.6pp over 30 days.
- P/E of 139 — priced for high growth; little margin of safety.
- Analyst mean target $119.75 — 22% above current (8 analysts).
BLLN closed at $98.51 (-0.66%) as of 2026-09-11. Market cap: $4.65B. P/E (trailing) 138.7. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $119.75 — 22% above current (8 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 29.6pp over 30 days.. Last quarter: Revenue $109.45M, net income $8.05M, free cash flow $12.03M.
Why three lenses on BLLN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLLNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BLLN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLLN brief"></iframe>